{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:41:46Z","timestamp":1774262506084,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006119.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000}}],"reference-count":100,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006119.pub3","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T21:07:41Z","timestamp":1410210461000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment"],"prefix":"10.1002","volume":"2018","author":[{"given":"Tilean","family":"Clarke","sequence":"first","affiliation":[{"name":"London Metropolitan University; 166-220 Holloway Rd London UK N7 8DB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadra","family":"Galaal","sequence":"additional","affiliation":[{"name":"Princess Alexandra Wing, Royal Cornwall Hospital; Gynaecological Oncology; Truro UK TR1 3LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Naik","sequence":"additional","affiliation":[{"name":"Northern Gynaecological Oncology Centre; Gynaecological Oncology; Queen Elizabeth Hospital Gateshead Tyne and Wear UK NE9 6SX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"key":"10.1002\/14651858.CD006119.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376 (9747)","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/bjc.2011.593","article-title":"CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial","volume":"106","author":"Alexandre","year":"2012","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD006119.pub3-BIB0003|cit3","first-page":"894","article-title":"Ovarian cancer","volume":"110","author":"Bapsy","year":"2012","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0027-9684(15)33511-2","article-title":"Screening CA-125 and transvaginal ultrasound does not reduce ovarian cancer mortality","volume":"104","author":"Buys","year":"2012","journal-title":"Journal of the National Medical Association"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/030089161109700502","article-title":"Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study.","volume":"97","author":"Fuso","year":"2011","journal-title":"Tumori"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/IGC.0b013e318212b87d","article-title":"No supportive evidence for clinical benefit of routine follow-up in ovarian cancer. A Dutch multicentre study","volume":"21","author":"Geurts","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11912-011-0199-3","article-title":"Recurrent ovarian cancer: when and how to treat","volume":"13","author":"Hall","year":"2011","journal-title":"Current Oncology Reports"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/j.ejrad.2012.03.020","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT scans for diagnosing ovarian cancer recurrence","volume":"81","author":"Kitajima","year":"2012","journal-title":"European Journal of Radiology"},{"issue":"10","key":"10.1002\/14651858.CD006119.pub3-BIB0009|cit9","first-page":"579","article-title":"Follow-up after primary therapy of malignant epithelial ovarian tumours (review)","volume":"112","author":"Lajtman","year":"2011","journal-title":"Bratislavske Lekarske Listy"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0010|cit10","first-page":"189","article-title":"The Gordon Rustin revolution - the measurement of CA125 in the surveillance of patients with ovarian cancer","volume":"13","author":"Madry","year":"2011","journal-title":"Family Medicine and Primary Care Review"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0011|cit11","first-page":"14","article-title":"Follow-up: what is evidence-based? Breast and gynecologic tumors","volume":"34","author":"Pastalozzi","year":"2011","journal-title":"Onkologie"},{"issue":"8","key":"10.1002\/14651858.CD006119.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/annonc\/mdr470","article-title":"Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up","volume":"22","author":"Pignata","year":"2011","journal-title":"Annals of Oncology"},{"issue":"8","key":"10.1002\/14651858.CD006119.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/annonc\/mdr471","article-title":"Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed","volume":"22","author":"Rustin","year":"2011","journal-title":"Annals of Oncology"},{"issue":"256","key":"10.1002\/14651858.CD006119.pub3-BIB0014|cit14","article-title":"The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial","volume":"12","author":"Poll-Franse","year":"2011","journal-title":"Trials Journal"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0015|cit15","unstructured":"Lanceley A A randomised study comparing satisfaction with follow-up led by a trained cancer nurse versus conventional medical follow-up after primary treatment for ovarian cancer"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006119.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/annonc\/mdn073","article-title":"Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up","volume":"19","author":"Aebi","year":"2008","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-8258(92)90216-6","article-title":"Clinical surveillance of gynecologic cancer patients","volume":"46","author":"Barnhill","year":"1992","journal-title":"Gynecological Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0018|cit18","first-page":"85","article-title":"Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma","volume":"153","author":"Barzen","year":"1990","journal-title":"R\u00f6Fo:Fortschritte auf dem Gebiete der R\u00f6ntgenstrahlen und derNuklearmedizin"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/01443610050112084","article-title":"What are the factors associated with the follow-up preferences of women in long-term remission from gynaecological cancer?","volume":"20","author":"Bradley","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"5A","key":"10.1002\/14651858.CD006119.pub3-BIB0021|cit21","first-page":"1353","article-title":"CA-125 monitoring in the management of ovarian cancer","volume":"10","author":"Bruzzone","year":"1990","journal-title":"Anticancer research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0022|cit22","first-page":"347","article-title":"Validity of gynaegnost in the follow-up of patients treated for ovarian cancer","volume":"84","author":"Cerejeira","year":"1989","journal-title":"Revue Fran\u00e7aise de Gyn\u00e9cologie et d'Obst\u00e9trique"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0023|cit23","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub3-BIB0024|cit24","first-page":"135","article-title":"Clinical significance of cancer antigen 125 CA 125 in ovarian cancer","volume":"8","author":"Crombach","year":"1985","journal-title":"Cancer detection and prevention"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2214\/ajr.176.3.1760701","article-title":"Role of chest CT in the follow-up of ovarian adenocarcinoma","volume":"176","author":"Dachman","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/02841869509127187","article-title":"The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer","volume":"34","author":"Engblom","year":"1995","journal-title":"Acta Oncologica (Stockholm Sweden)"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary","volume":"14 (Supplement","author":"Sant","year":"2003","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/1998\/738321","article-title":"The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer","volume":"14","author":"Fayed","year":"1998","journal-title":"Disease Markers"},{"issue":"3A","key":"10.1002\/14651858.CD006119.pub3-BIB0029|cit29","first-page":"1551","article-title":"Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients","volume":"25","author":"Fehm","year":"2005","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-8258(92)90031-D","article-title":"The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients","volume":"44","author":"Fioretti","year":"1992","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jcp.42.1.40","article-title":"Serum placental-like alkaline phosphatase PLAP: a novel combined enzyme linked immunoassay for monitoring ovarian cancer","volume":"42","author":"Fisken","year":"1989","journal-title":"Journal of Clinical Pathology"},{"issue":"6B","key":"10.1002\/14651858.CD006119.pub3-BIB0032|cit32","first-page":"2683","article-title":"The measurement of plasma D-dimer DD levels in the follow-up of patients with ovarian cancer","volume":"15","author":"Gadducci","year":"1995","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0033|cit33","first-page":"21","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0212-6982(03)72189-2","article-title":"F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125","volume":"22","author":"Garc\u00eda","year":"2003","journal-title":"Revista Espanola de Medicina Nuclear"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0035|cit35","first-page":"320","article-title":"Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 724, SCC, 90 K","volume":"112","author":"Garzetti","year":"1991","journal-title":"Annali di Ostetricia, Ginecologia, Medicina Perinatale"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0036|cit36","unstructured":"Ferlay J Soerjomataram I Ervik M Dikshit R Eser S Mathers C GLOBOCAN 2012.\u00a0Cancer incidence, mortality worldwide IARC CancerBase No. 11, version 1.0.\u00a0 IARCPress, Lyon 2012"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(07)70273-5","article-title":"Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations","volume":"8(9)","author":"Goonewardene","year":"2007","journal-title":"Lancet Oncology"},{"issue":"10","key":"10.1002\/14651858.CD006119.pub3-BIB0038|cit38","first-page":"746","article-title":"The value of FDG PET\/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma","volume":"77","author":"Grabiec","year":"2006","journal-title":"Ginekologia Polska"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0040|cit40","first-page":"171","article-title":"Abdominal computerized tomography in the after-care of ovarian cancers","volume":"6","author":"Gritzmann","year":"1986","journal-title":"Digitale Bilddiagnostik"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.313.7058.665","article-title":"Routine follow up of breast cancer in primary care: randomised trial","volume":"313","author":"Grunfeld","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejrad.2005.04.006","article-title":"Evaluation of integrated whole-body PET\/CT in the detection of recurrent ovarian cancer","volume":"56","author":"Hauth","year":"2005","journal-title":"European Journal of Radiology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0043|cit43","first-page":"6","article-title":"Predictive value of the tumor marker combination CA-125 and beta-2- microglobulin in ovarian cancer","volume":"114","author":"Hern\u00e1di","year":"1992","journal-title":"Zentralblatt f\u00fcr Gyn\u00e4kologie"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub3-BIB0044|cit44","first-page":"263","article-title":"Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer","volume":"6","author":"Hetzel","year":"1983","journal-title":"Cancer Detection and Prevention"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00000421-199104000-00003","article-title":"Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients","volume":"14","author":"Hising","year":"1991","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0046|cit46","article-title":"Cancer Incidence in Five Continents, Volume VIII","volume-title":"IARC Scientific Publication No 155","author":"Parkin","year":"2002"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub3-BIB0047|cit47","first-page":"1799","article-title":"Tissue polypeptide antigen as a tumor marker for gynecologic malignancies","volume":"37","author":"Inoue","year":"1985","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0048|cit48","first-page":"1256","article-title":"Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels","volume":"24","author":"Iwanari","year":"1989","journal-title":"Nippon Gan Chiryo Gakkai Shi"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacr.2007.05.019","article-title":"ACR Appropriateness Criteria on staging and follow-up of ovarian cancer","volume":"4","author":"Javitt","year":"2007","journal-title":"Journal of the American College of Radiology"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0050|cit50","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"17","key":"10.1002\/14651858.CD006119.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF01732187","article-title":"Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer CA 125 as a tumor marker A cooperative study of the Gynecologic Tumor Marker Group GTMG","volume":"64","author":"Kaesemann","year":"1986","journal-title":"Klinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1479-828X.1995.tb01986.x","article-title":"Follow-up of patients with gynaecological cancer","volume":"35","author":"Kerr-Wilson","year":"1995","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/ijgc-00009577-200505000-00001","article-title":"The role of routine follow-up after gynecological malignancy","volume":"15","author":"Kew","year":"2005","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Kew FM Cruickshank DJ Routine follow up after treatment for a gynaecological cancer: a survey of practice International Journal of Gynecological Cancer 2006 380 4","DOI":"10.1111\/j.1525-1438.2006.00421.x"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.159.1.3513245","article-title":"Ovarian carcinoma follow-up: US versus laparotomy","volume":"159","author":"Khan","year":"1986","journal-title":"Radiology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/1097-0142(197409)34:3<542::AID-CNCR2820340311>3.0.CO;2-K","article-title":"Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer","volume":"34","author":"Khoo","year":"1974","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(197906)43:6<2471::AID-CNCR2820430644>3.0.CO;2-E","article-title":"Predictive value of serial carcinoembryonic antigen levels in long-term follow-up of ovarian cancer","volume":"43","author":"Khoo","year":"1979","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/rct.0b013e31803e8c45","article-title":"Detection of recurrent ovarian cancer at MRI: comparison with integrated PET\/CT","volume":"31","author":"Kim","year":"2007","journal-title":"Journal of Computer Assisted Tomography"},{"issue":"8","key":"10.1002\/14651858.CD006119.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00259-008-0776-3","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET\/non-contrast-enhanced CT and enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"European Journal of Nuclear Medicine & Molecular Imaging"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0060|cit60","first-page":"15","article-title":"Clinical usefulness of serum sialyl Lex-i measurement in patients with ovarian cancer","volume":"41","author":"Kobayashi","year":"1989","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","article-title":"Value of 18F-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma","volume":"10","author":"Kubik","year":"2000","journal-title":"European Radiology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0936-6555(05)81037-4","article-title":"The value of follow-up in stage II carcinoma of the cervix","volume":"3","author":"Kunkler","year":"1991","journal-title":"Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/1097-0142(19871101)60:9<2228::AID-CNCR2820600921>3.0.CO;2-N","article-title":"The predictive value of a combination of tumor markers in monitoring patients with ovarian cancer","volume":"60","author":"Lahousen","year":"1987","journal-title":"Cancer"},{"issue":"5-6","key":"10.1002\/14651858.CD006119.pub3-BIB0064|cit64","first-page":"389","article-title":"Clinical correlations of carcinoembryonic antigen in post-operative patients with epithelial ovarian cancer","volume":"7","author":"Lenehan","year":"1986","journal-title":"Tumour Biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"4C","key":"10.1002\/14651858.CD006119.pub3-BIB0065|cit65","first-page":"2303","article-title":"PET-CT in recurrent ovarian cancer: impact on treatment planning","volume":"28","author":"Lenhard","year":"2008","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiology.211.2.r99ma24519","article-title":"Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study","volume":"211","author":"Low","year":"1999","journal-title":"Radiology"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00259-006-0306-0","article-title":"Integrated PET\/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer","volume":"34","author":"Mangili","year":"2007","journal-title":"European Journal of Nuclear Medicine & Molecular Imaging"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2006.02.005","article-title":"Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels","volume":"103","author":"Menczer","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.325.7373.1145","article-title":"Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial","volume":"325","author":"Moore","year":"2002","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","article-title":"Clinical value of positron emission tomography with FDG for recurrent ovarian cancer","volume":"176","author":"Nakamoto","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"4A","key":"10.1002\/14651858.CD006119.pub3-BIB0071|cit71","first-page":"2513","article-title":"CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer","volume":"19","author":"Oehler","year":"1999","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0072|cit72","first-page":"363","article-title":"Assessment of ovarian tumors by transvaginal scanning and clinical significance of ultrasonic examination in postoperative follow up","volume":"40","author":"Okai","year":"1992","journal-title":"Rinsho Byori. The Japanese Journal of Clinical Pathology"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1525-1438.2001.01042.x","article-title":"A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study","volume":"11","author":"Olaitan","year":"2001","journal-title":"International Journal of Gynecologic Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2005.11.046","article-title":"A study to evaluate the use of CA125 in ovarian cancer follow-up: a change in practice led by patient preference","volume":"101","author":"Palmer","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2005.08.057","article-title":"The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer","volume":"100","author":"Parker","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"24","key":"10.1002\/14651858.CD006119.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Erratum in Statistics in Medicine 2004 Jun 15;23(11):1817","volume":"17","author":"Parmar","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00004728-199307000-00021","article-title":"CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer","volume":"17","author":"Prayer","year":"1993","journal-title":"Journal of Computer Assisted Tomography"},{"key":"10.1002\/14651858.CD006119.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.324.7341.813","article-title":"Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials","volume":"324","author":"Renehan","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.bjc.6602369","article-title":"Mechanisms of improved survival from intensive follow up in colorectal cancer: a hypothesis","volume":"92","author":"Renehan","year":"2005","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"353-366","DOI":"10.1080\/13698570903013623","article-title":"Future disorientation following gynaecological cancer: Women\u2019s conceptualisation of risk after a life threatening illness","volume":"11","author":"Roberts","year":"2009","journal-title":"Health, Risk & Society"},{"issue":"9021","key":"10.1002\/14651858.CD006119.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(05)66133-8","article-title":"Use of CA 125 in follow-up of ovarian cancer","volume":"348","author":"Rustin","year":"1996","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD006119.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1158\/1078-0432.CCR-03-0365","article-title":"Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer","volume":"10","author":"Schorge","year":"2004","journal-title":"Clinical Cancer Research: an official journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2214\/ajr.177.4.1770857","article-title":"Value of chest CT scans in routine ovarian carcinoma follow-up","volume":"177","author":"Sella","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub3-BIB0084|cit84","first-page":"554","article-title":"Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects","volume":"38","author":"Shimizu","year":"1986","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub3-BIB0085|cit85","first-page":"53","article-title":"Follow-up laparoscopy in patients with ovarian cancer","volume":"19","author":"Shinozuka","year":"1994","journal-title":"The Tokai Journal of Experimental and Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0086|cit86","first-page":"1127","article-title":"Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer","volume":"15","author":"Sliutz","year":"1995","journal-title":"Anticancer Research"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0087|cit87","first-page":"5","article-title":"The views of ovarian cancer survivors on its cause, prevention, and recurrence","volume":"6","author":"Stewart","year":"2001","journal-title":"Medscape Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0088|cit88","first-page":"213","article-title":"Feasibility of peritoneal washing cytology through the totally implanted reservoir for early detection of peritoneal recurrence of ovarian cancer","volume":"48","author":"Sugiyama","year":"1996","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1097-0215(19980619)79:3<241::AID-IJC5>3.0.CO;2-P","article-title":"Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients","volume":"79","author":"Tempfer","year":"1998","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1469-0705.2002.00693.x","article-title":"Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy","volume":"19","author":"Testa","year":"2002","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ygyno.2005.07.116","article-title":"The role of sonographic examination in the follow-up of gynecological neoplasms","volume":"99","author":"Testa","year":"2005","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography FDG-PET\/CT in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","article-title":"Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy- D-glucose","volume":"29","author":"Torizuka","year":"2002","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/003655102317475434","article-title":"Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up","volume":"62","author":"Tuxen","year":"2002","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0093-7754(03)00100-3","article-title":"The follow-up of ovarian cancer","volume":"30","author":"Vaidya","year":"2003","journal-title":"Seminars in Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0090-8258(80)90064-5","article-title":"Follow-up study of ovarian carcinoma by cytology of cul-de-sac aspirates","volume":"10","author":"VillaSanta","year":"1980","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0097|cit97","first-page":"205","article-title":"Tumor marker CA 125 in diagnosis, monitoring management and follow-up of patients with ovarian tumors","volume":"13","author":"Vinokurov","year":"1992","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0098|cit98","first-page":"1015","article-title":"Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma","volume":"27","author":"Vuento","year":"2007","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub3-BIB0099|cit99","first-page":"356","article-title":"Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma","volume":"37","author":"Zhu","year":"2002","journal-title":"Zhonghua Fu Chan Ke za Zhi"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/gyno.2001.6386","article-title":"2-Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer","volume":"83","author":"Zimny","year":"2001","journal-title":"Gynecologic Oncology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006119.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006119.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T08:21:10Z","timestamp":1676622070000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006119.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":100,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006119.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006119.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,8]]}}}